Interstitial lung disease (ILD) — a heterogeneous group of over 200 disorders characterised by inflammation and fibrosis of the lung parenchyma — ranges from treatable conditions (hypersensitivity pneumonitis, cryptogenic organising pneumonia, sarcoidosis) to progressive incurable fibrosis (idiopathic pulmonary fibrosis — IPF). IPF, the most common and most serious form, causes relentless progressive fibrosis with a median survival of 3–5 years from diagnosis. ILD requires respiratory specialist diagnosis (high-resolution CT, bronchoscopy, and often surgical lung biopsy) and specialist management. Antifibrotic drugs (pirfenidone, nintedanib) slow IPF progression and are non-negotiable in eligible patients. Constitutional homeopathy addresses the breathlessness, dry cough, fatigue, and constitutional inflammatory pattern as an adjunct to specialist pulmonary care.
Diagnosis and Classification of ILD
ILD is classified by aetiology: idiopathic interstitial pneumonias (IPF — the most common and most progressive; NSIP; COP; DIP; RB-ILD); connective tissue disease-associated ILD (rheumatoid arthritis-ILD, SSc-ILD, myositis-ILD, Sjögren's-ILD); hypersensitivity pneumonitis (HP — from avian exposure, mould, or occupational antigens); sarcoidosis; and drug-induced ILD (methotrexate, amiodarone, nitrofurantoin). Diagnosis requires: clinical history (occupational exposures, medications, connective tissue disease features); pulmonary function tests (restrictive pattern — reduced FVC, TLC, and DLCO); high-resolution CT chest (UIP pattern in IPF — basal-predominant honeycombing with traction bronchiectasis); BAL; and surgical lung biopsy when diagnosis is uncertain. MDT review is essential before treatment decisions.
Antifibrotic Treatment and Pulmonary Rehabilitation
IPF treatment: pirfenidone and nintedanib are approved antifibrotic agents that slow FVC decline by approximately 50% — both are indicated in patients with FVC > 50% predicted; both have significant side effects (GI intolerance, photosensitivity for pirfenidone; diarrhoea for nintedanib); neither halts progression. Lung transplantation offers the only potential for cure in eligible patients (typically under 65, without major comorbidities). Pulmonary rehabilitation significantly improves exercise tolerance, quality of life, and 6-minute walk distance. Long-term oxygen therapy for patients with resting hypoxaemia (SpO2 < 88%). Connective tissue disease-ILD is managed with immunosuppression (mycophenolate, azathioprine); HP requires antigen avoidance. COP and sarcoidosis typically respond to corticosteroids.
Constitutional Homeopathic Approach
Constitutional homeopathy for ILD addresses the specific symptom profile (breathlessness pattern — at rest, on exertion, or nocturnal; dry cough character — hacking, tickling, or paroxysmal; fatigue quality — post-exertional or constant), the constitutional inflammatory tendency (the fibrotic, progressive constitutional type), the emotional response to a progressive lung disease (anxiety, fear of breathlessness, anticipatory fear), and the constitutional type. Treatment over 6 to 12 months aims to reduce the cough intensity, improve exercise tolerance within the limits of the structural disease, reduce anxiety about breathlessness, and support the best possible quality of life alongside pulmonary rehabilitation and antifibrotic therapy.
Key Remedies
Arsenicum Album addresses ILD with breathlessness worse on lying down, anxiety about suffocation, restlessness, and the midnight-aggravated, exhausted, chilly constitutional type — the fear of death from respiratory failure and the burning chest discomfort of progressive fibrosis. Phosphorus suits ILD in the tall, lean, warm-blooded, sympathetic constitutional type — the burning chest tightness, hard dry cough, and haemorrhagic tendency; particularly suited to IPF with honeycombing and haemoptysis tendency. Stannum Metallicum addresses progressive pulmonary weakness and debility — the profound respiratory weakness, profuse expectoration, and the collapsing, exhausted feeling from chronic lung disease. Silicea suits ILD with a slow, suppurating, fibrotic constitutional tendency — the chilly, sweating, lacking-in-stamina constitution with progressive scarring and fibrosis of the lungs.
Key Points at a Glance
Antifibrotic drugs (pirfenidone, nintedanib) slow IPF progression — they are non-negotiable in eligible patients
High-resolution CT is the key diagnostic investigation — UIP pattern (basal honeycombing) is characteristic of IPF
MDT review including respiratory physician, radiologist, and pathologist is required before ILD treatment decisions
Arsenicum Album suits breathlessness with nocturnal worsening, anxiety about suffocation, and profound restlessness
Pulmonary rehabilitation improves exercise tolerance and quality of life even in progressive ILD
Seeking constitutional support for breathlessness and fatigue in interstitial lung disease?
Dr. Meera Thakur offers constitutional homeopathic support for ILD at HealthKunj Clinics, Kharadi, Pune — reducing breathlessness, dry cough, and fatigue as an adjunct to specialist pulmonary management.
Book Free Consultation
Dr. Meera Thakur
BHMS · HealthKunj Clinics, Kharadi, Pune
Dr. Meera has 15+ years of experience in individualised homeopathic practice with a special interest in women's hormonal health, skin disorders, and paediatric care.
Read full profile